Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.
about
Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine.Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in micePrevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriersEpitope-based vaccine against influenza.Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.Flagellin as an adjuvant: cellular mechanisms and potential.Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.Intranasal immunization of lambs with serine/threonine phosphatase 2A against gastrointestinal nematodes.Bacterial flagellin-a potent immunomodulatory agent.DNA-vaccine platform development against H1N1 subtype of swine influenza A viruses.Cloning of fliC Gene From Salmonella typhimurium in the Expression Vector pVAX1 and Evaluation of its Expression in Eukaryotic Cells.Computational Identification and Characterization of a Promiscuous T-Cell Epitope on the Extracellular Protein 85B of Mycobacterium spp. for Peptide-Based Subunit Vaccine DesignInduction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.Towards a universal influenza vaccine: different approaches for one goal.Intranasal immunization with a peptide conjugated to Salmonella flagellin induces both systemic and mucosal peptide-specific antibody responses in mice.
P2860
Q30412800-E5B2C46D-B466-46C7-92D9-115D3FB4BE4CQ30879279-2B3AE3AC-BA92-49DD-9CA8-F5F17E5D05E6Q33904706-8BBDB5CA-B444-4DBC-9D96-E06D8B62C692Q33905188-50CBF653-A4AC-4E69-8750-02BAB621D672Q34200500-628C53D0-42DC-4AA5-97FA-94E1B302B710Q37012089-90325809-C2FC-4551-898E-0DA0D816217CQ37051021-6F1EB0CB-6D12-4018-A902-78DEC752E80AQ37130379-902866D9-4FAF-460D-A1E1-A7BB3613944FQ37426304-0B88E814-D803-4B55-AED4-404FCE070757Q37469672-A782E5FE-EDBE-4725-AC64-AD4390F67ACBQ38634734-28160CB4-4AD7-4CC7-917B-BAF4EDD8C032Q39311178-3FF09D5E-2C84-4D74-92E4-AD86BA36067AQ39505278-67DF4425-7A71-4EC2-B554-694361BEA92DQ42177811-FBCC59F2-FB5B-489D-83E4-550AADE14590Q43620105-4FD4DCF7-3C6F-4D07-948B-9E651ED77422Q47548866-BB8CE2C5-C128-4F84-91AF-33762EC36E5CQ49964472-EF3DEBED-380B-4B2D-9149-6877D32BFD17
P2860
Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Intranasal administration of p ...... mera from influenza infection.
@en
Intranasal administration of p ...... mera from influenza infection.
@nl
type
label
Intranasal administration of p ...... mera from influenza infection.
@en
Intranasal administration of p ...... mera from influenza infection.
@nl
prefLabel
Intranasal administration of p ...... mera from influenza infection.
@en
Intranasal administration of p ...... mera from influenza infection.
@nl
P2093
P2860
P356
P1476
Intranasal administration of p ...... imera from influenza infection
@en
P2093
P2860
P304
P356
10.1093/INTIMM/11.7.1043
P50
P577
1999-07-01T00:00:00Z